Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc

Yongtao Han1,727 enrolled

Overview

The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy.. The main question\[s\] it aims to answer is: * provide a basis for accurate staging and the relationship between OS and lymph node dissection

Study Type

OBSERVATIONAL

Enrollment

1,727

Conditions

Esophageal Cancer

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0) 2. Underwent esophagecomy (two-field or three-field LN dissection) 3. The primary tumor was thoracic ESCC Exclusion Criteria: 1. Located outside the thoracic 2. Patients underwent salvage or R1/R2 esophagecomy 3. The number of resected lymph nodes (RLNs) less than 15 4. With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)

Locations (1)

Sichuan Cancer Hospital and Research Institute

Chengdu, Sichuan, China

Outcomes

Primary Outcomes

5-year survival rate of lymph nodes metastases (%) in patients

Surgical data were retrospectively collected

Time frame: 2010.1.1-2017.12.30

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.